Potassium Citrate 1080mgTablet
Urology & Nephrology

Potassium Citrate 1080mg

Potassium Citrate

Extended-release urinary alkalinizer that raises urinary pH and citrate concentration to inhibit calcium oxalate and uric acid crystal formation, significantly reducing recurrence rates of nephrolithiasis. The wax-matrix formulation ensures sustained alkalinisation throughout the day, making compliance straightforward with twice or thrice daily dosing alongside meals.

Strengths

5mEq / 10mEq / 1080mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Potassium Citrate 1080mg (extended release wax matrix tablet)
Dosage Form
Tablet
Available Strengths
5mEq / 10mEq / 1080mg
Packing
10 tablets/strip
Route of Administration
Oral, with meals and a full glass of water
Dosage
Initial: 10-20 mEq three times daily with meals; adjust based on 24-hour urinary citrate and pH; target urine pH 6.0-7.0
Indications
Calcium oxalate nephrolithiasis, uric acid nephrolithiasis, renal tubular acidosis with stones, hypocitraturia, distal RTA
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
36 months
Side Effects
Nausea, vomiting, diarrhea, abdominal discomfort, hyperkalemia
Precautions
Monitor serum potassium levels; avoid in hyperkalemia; caution with ACE inhibitors, ARBs, potassium-sparing diuretics; swallow whole (wax matrix); ensure adequate hydration

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Dutasteride 0.5mgCapsule

Dutasteride 0.5mg

Dutasteride

Dual-isoform 5-alpha reductase inhibitor (types I and II) providing more complete DHT suppression than finasteride, leading to clinically significant prostate volume reduction and improved urinary flow in benign prostatic hyperplasia. Long-term therapy reduces the risk of acute urinary retention and the need for surgical intervention, with benefit becoming evident after 3-6 months of continuous treatment.

0.5mg
Solifenacin 5mgTablet

Solifenacin 5mg

Solifenacin Succinate

Selective M3 muscarinic receptor antagonist that reduces detrusor muscle overactivity, providing clinically meaningful reductions in urinary urgency episodes, voiding frequency, and urge incontinence. Once-daily dosing with a long half-life ensures consistent 24-hour bladder control, and the dose can be titrated from 5mg to 10mg based on individual response and tolerability.

5mg / 10mg
Mirabegron 50mgTablet

Mirabegron 50mg

Mirabegron

First beta-3 adrenoceptor agonist for overactive bladder providing an alternative to antimuscarinics without dry mouth or constipation. Manufactured by Sun Pharma for urology export.

25mg / 50mg

Need bulk pricing for Potassium Citrate 1080mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote